Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex interacting protein family member B1, pseudogene (NPIPB1P) is a human pseudogene located on chromosome 16. It does not encode a functional protein product and is therefore not considered biologically active or therapeutically relevant. NPIPB1P is annotated in several genetic databases as a non-coding genomic locus related to the nuclear pore complex interacting protein family, but lacking the capacity to produce a protein due to genetic mutations or disruptions[1][4][5]. There is no evidence of NPIPB1P being implicated in disease, targeted by drugs, used as a biomarker, or having safety concerns in the clinical context. Detection of NPIPB1P is only relevant for genetic annotation and research into pseudogene biology, not for molecular pharmacology or therapeutic development[1][4][5].
None. Pseudogenes do not have mechanisms of action relevant to pharmacology or drug targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein family member B1, pseudogene (NPIPB1P).